Skip Main Navigation
Page Content

Save This Event

Event Saved

Sell Your Science: Best Practices for Developing an Effective Non-Confidential Pitch Deck

Johnson & Johnson Innovation, JLABS

Tuesday, 20 June 2017 from 19:00 to 21:00 (CEST)

Sell Your Science: Best Practices for Developing an...

Registration Information

Type End Quantity
General Public
The event is on 20 June, but online ticket sales end on 19 June.
19 Jun 2017 Free  
Media/Press   more info 19 Jun 2017 Free  

Share Sell Your Science: Best Practices for Developing an Effective Non-Confidential Pitch Deck

Event Details

It can be tricky to communicate the full potential of your discoveries without spilling the secret sauce. Join us for a session on learning the tricks of the trade in preparing a non-confidential deck and executive summary. Experts of the craft will share practical tips on becoming more effective in communicating your story to investors, increasing your chances of successful fundraising.


Speakers
Jeanne Bolger | VP, Venture Investments, Johnson & Johnson Innovation - JJDC read bio»
Alain Huriez | Manager, Advent Life Sciences read bio»
Henrijette Richter | Partner, Sofinnova read bio»


Agenda
19:00 | Registration Opens and Networking (Light Food & Beverages)
19:30 | Presentation, Q&A, and Panel
21:00 | Programme Close


Event partners

Maddyness

Maddyness  
 
USINE


Who should attend
This workshop is ideal for inventors in academic centers and hospitals, and early stage healthcare start-ups in the pharma, medical device, consumer health and digital innovation areas.


Fees
FREE | There is no cost to attend this workshop, but pre-registration is required.


Location
Usine IO
181 rue du Chevaleret
75013 Paris, France


Speakers' biographies
Jeanne Bolger, MB BCh | Vice President, Venture Investments, Johnson & Johnson Innovation - JJDC
Jeanne joined Johnson & Johnson Innovation - JJDC as Vice President, Venture Investments, in February 2013. She is based in London, UK at the Johnson & Johnson Innovation Centre. Jeanne's responsibilities are focused on investing in and managing portfolio investments in the pharmaceuticals and biotechnology areas in Europe.
Jeanne has over 25 years of pharmaceutical industry experience in management roles across R+D, Commercial and Business Development. She spent 11 years in Licensing and Acquisition, most recently as Global Head of Scientific Licensing for Johnson & Johnson's Pharmaceutical business, having joined the Johnson & Johnson Family of Companies in 2005 from the Business Development group at GSK.
In 2009, Jeanne became VP Alliance Management and Board Director at Janssen Alzheimer Immunotherapy, working with Pfizer and Elan on immunotherapies targeting beta amyloid for Alzheimer's disease.
Jeanne received her medical degree from University College Dublin. She also holds diplomas in Child Health (NUI) and in Finance and Accounting (ACCA). She is a Fellow of the Royal Academy of Medicine of Ireland (RAMI). She has served as the sole pharmaceutical industry representative on two Irish government taskforces seeking to enhance the commercialization of IP from Irish academic centres. She is a visiting lecturer on the MSc Pharmaceutical Medicine curriculum at Trinity College in Dublin, Ireland.
Connect with Jeanne:   Connect on LinkedIn



Alain Huriez, MD | Partner, Advent Life Sciences
Alain brings over 30 years of experience in the Life Sciences sector. He started his career in the mid 1980's as head of the emergency room in a large teaching hospital (CHU Amiens) and practiced as a General Practitioner for four years. He spent 12 years in biotechnology drug development and regulatory strategy before being appointed Vice President of Quintiles in Europe. Later on he became a Life Sciences entrepreneur, Associate Partner at Truffle Capital, CEO of Neovacs and TcLand (TcLand Expression and Effimune). He has successfully founded 5 French biotechnology companies. He has been involved in personalized medicine, biomarker and high value diagnostics through his work as Founder and Chairman of EPEMED, the European Personalized Medicine Association. Alain joined Advent Life Sciences in 2012 and founded Advent France Biotechnology with Matthieu Coutet in 2016. Alain's medical and biotechnological background, experience as an entrepreneur and a leading executive, expertise in clinical development and financing as well as his networks are keys to identifying early-stage biotechnology projects and to mentoring managers into building successful businesses. Alain graduated as a Medical Doctor from Picardie Jules Verne University (Amiens). He holds a MBA and a Master in Pharmaco-Economics from La Sorbonne University (Paris).
Connect with Alain:   Connect on LinkedIn



Henrijette Richter, Ph.D. | Partner, Sofinnova
Henrijette Richter is Partner at Sofinnova Partners, Paris. She joined in 2014 from Novo Seeds (part of Novo A/S) where she was involved in the establishment of the group in 2007. While at Novo Seeds Henrijette was instrumental in the creation, financing and building of companies such as Cytoguide, Orphazyme, Avilex Pharma, EpiTherapeutics (sold to Gilead) and Lysogene. Henrijette is a scientist by training and started her career at Novo Nordisk conducting her Ph.D. in the area of obesity and GH signalling. Before joining Sunstone Capital in 2004, Henrijette was a postdoctoral fellow at the MIT Center for Cancer Research (MA). Henrijette invested in and is a board member of Asceneuron (CH), Delinia and Chairwoman of the board of iOmx. She is a member of WITH (Women innovating together in Healthcare).
Connect with Henrijette:   Connect on LinkedIn


Do you have questions about Sell Your Science: Best Practices for Developing an Effective Non-Confidential Pitch Deck? Contact Johnson & Johnson Innovation, JLABS

Save This Event

Event Saved

When & Where


Usine IO
181 rue du Chevaleret
75013 Paris
France

Tuesday, 20 June 2017 from 19:00 to 21:00 (CEST)


  Add to my calendar

Organiser

Johnson & Johnson Innovation, JLABS

About Johnson & Johnson Innovation, JLABS
Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and digital health sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to eight locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto and a ninth location, New York City, launching in 2018. For more information please visit jlabs.jnjinnovation.com.

About Johnson & Johnson Innovation
Johnson & Johnson Innovation Limited focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers, JLABS, Johnson & Johnson Innovation - JJDC, and our Business Development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. For more information please visit www.jnjinnovation.com.

  Contact the Organiser
Sell Your Science: Best Practices for Developing an Effective Non-Confidential Pitch Deck
Things to do in Paris Course Business

Interested in hosting your own event?

Join millions of people on Eventbrite.

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.